| Dr Robert M Spillane, MD | |
|
111 Founders Plz, Suite 400, East Hartford, CT 06108-3212 | |
| (860) 289-3375 | |
| (860) 560-2849 |
| Full Name | Dr Robert M Spillane |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 111 Founders Plz, East Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033161088 | NPI | - | NPPES |
| 1033161088 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 041901 (Connecticut) | Primary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 041901 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| William W Backus Hospital | Norwich, CT | Hospital |
| The Hospital Of Central Connecticut | New britain, CT | Hospital |
| Midstate Medical Center | Meriden, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meriden Imaging Center Inc | 4385683556 | 49 |
| Midstate Radiology Associates, Llc | 4880593565 | 73 |
News Archive
A study published in the April 2009 issue of the medical journal Acta Paediatrica is the first to report that birth defect rates in the United States were highest for women conceiving in the spring and summer. The researchers also found that this period of increase risk correlated with increased levels of pesticides in surface water across the United States.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
| Entity Name | Midstate Radiology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578518999 PECOS PAC ID: 4880593565 Enrollment ID: O20031231000543 |
News Archive
A study published in the April 2009 issue of the medical journal Acta Paediatrica is the first to report that birth defect rates in the United States were highest for women conceiving in the spring and summer. The researchers also found that this period of increase risk correlated with increased levels of pesticides in surface water across the United States.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
| Entity Name | Diagnostic Imaging Services Of Ct Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093760431 PECOS PAC ID: 3577465111 Enrollment ID: O20040123000288 |
News Archive
A study published in the April 2009 issue of the medical journal Acta Paediatrica is the first to report that birth defect rates in the United States were highest for women conceiving in the spring and summer. The researchers also found that this period of increase risk correlated with increased levels of pesticides in surface water across the United States.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
| Entity Name | Hospital For Special Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477534089 PECOS PAC ID: 7810985637 Enrollment ID: O20040506000578 |
News Archive
A study published in the April 2009 issue of the medical journal Acta Paediatrica is the first to report that birth defect rates in the United States were highest for women conceiving in the spring and summer. The researchers also found that this period of increase risk correlated with increased levels of pesticides in surface water across the United States.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
| Entity Name | Meriden Imaging Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508812561 PECOS PAC ID: 4385683556 Enrollment ID: O20050427000621 |
News Archive
A study published in the April 2009 issue of the medical journal Acta Paediatrica is the first to report that birth defect rates in the United States were highest for women conceiving in the spring and summer. The researchers also found that this period of increase risk correlated with increased levels of pesticides in surface water across the United States.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert M Spillane, MD 18 Bainbridge Rd, West Hartford, CT 06119-1101 Ph: (860) 289-3375 | Dr Robert M Spillane, MD 111 Founders Plz, Suite 400, East Hartford, CT 06108-3212 Ph: (860) 289-3375 |
News Archive
A study published in the April 2009 issue of the medical journal Acta Paediatrica is the first to report that birth defect rates in the United States were highest for women conceiving in the spring and summer. The researchers also found that this period of increase risk correlated with increased levels of pesticides in surface water across the United States.
A new study by NYU Langone Medical Center and Northwestern University Feinberg School of Medicine shows novel PSA velocity (PSAV) risk count testing may provide a more effective way for physicians to screen men for clinically significant prostate cancer.
Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of New Jersey denied Teva's motion to overturn an April 23, 2010, jury verdict finding the patent in suit not invalid. The Court also denied Wyeth and Nycomed's request for FDA to reset the date of Teva's final approval to January 2011, based on the fact that Teva has patent defenses remaining at the District Court, including patent misuse.
› Verified 5 days ago
Susan Davis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz Ste 400, East Hartford, CT 06108 Phone: 860-289-3375 | |
Sean Richardson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz Ste 400, East Hartford, CT 06108 Phone: 860-289-3375 | |
Payam Sajedi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz Ste 400, East Hartford, CT 06108 Phone: 860-289-3375 Fax: 860-783-5733 | |
Daniel Collins, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz Ste 400, East Hartford, CT 06108 Phone: 860-289-3375 Fax: 860-783-5733 | |
Dr. Joseph A Lembo Iii, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz Ste 400, East Hartford, CT 06108 Phone: 860-289-3375 Fax: 860-783-5733 | |
Steve Y Lee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 111 Founders Plz, Ste. 400, East Hartford, CT 06108 Phone: 860-289-3375 Fax: 860-783-5733 |